| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0379-0738(00)00426-6 |
| P698 | PubMed publication ID | 11376982 |
| P2093 | author name string | Levine B | |
| Miller ML | |||
| LeBeau MA | |||
| P2860 | cites work | Prevalence of drugs used in cases of alleged sexual assault | Q33864897 |
| A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management | Q40855675 | ||
| Sites of action of gamma-hydroxybutyrate (GHB)--a neuroactive drug with abuse potential | Q40910671 | ||
| Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans | Q44578620 | ||
| Formation and regional distribution of gamma-hydroxybutyric acid in mammalian brain | Q46660909 | ||
| Metabolism of gamma-hydroxy-[1-14C] butyrate by rat brain: relationship to the Krebs cycle and metabolic compartmentation of amino acids | Q48185399 | ||
| Identification and quantitation of 1,4-butanediol in mammalian tissues: an alternative biosynthetic pathway for gamma-hydroxybutyric acid | Q48487656 | ||
| Conversion in vivo of γ-aminobutyric to γ-hydroxybutyric acid in the rat | Q49082019 | ||
| Driving under the influence of GHB? | Q50115216 | ||
| Drugs used in acquaintance rape | Q50143460 | ||
| Analysis of biofluids for gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) by headspace GC-FID and GC-MS. | Q51379017 | ||
| Chemical submission: GHB, benzodiazepines, and other knock out drops. | Q51551230 | ||
| The Extraneural Distribution of γ‐Hydroxybutyrate | Q70977768 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 161-167 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Forensic Science International | Q15766274 |
| P1476 | title | Effect of storage temperature on endogenous GHB levels in urine | |
| P478 | volume | 119 |
| Q37872702 | Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). |
| Q44438246 | Forensic cases involving the use of GHB in The Netherlands |
| Q38098580 | Forensic toxicology in drug-facilitated sexual assault |
| Q34533565 | Gamma hydroxybutyric acid (GHB) concentrations in humans and factors affecting endogenous production |
| Q44597346 | Gamma-hydroxybutyric acid (GHB) measurement by GC-MS in blood, urine and gastric contents, following an acute intoxication in Belgium |
| Q37268694 | Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse |
| Q46908782 | Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL - an experiment with two volunteers |
| Q94949829 | Phase I metabolites (organic acids) of gamma-hydroxybutyric acid -validated quantification by GC-MS and description of endogenous concentration ranges |
| Q37940945 | Potential impact of drug effects, availability, pharmacokinetics, and screening on estimates of drugs implicated in cases of assault |
| Q43913297 | Production of gamma-hydroxybutyric acid in postmortem liver increases with time after death |
| Q37810147 | Retrospective drug detection in cases of drug-facilitated sexual assault: challenges and perspectives for the forensic toxicologist |
| Q38185603 | Screening and confirmation methods for GHB determination in biological fluids |
| Q47752383 | Stability of γ-Hydroxybutyrate in Blood Samples from Impaired Drivers after Storage at 4°C and Comparison of GC-FID-GBL and LC-MS-MS Methods of Analysis |
| Q90622403 | The challenge of post-mortem GHB analysis: storage conditions and specimen types are both important |
Search more.